These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12543699)

  • 21. Ceftriaxone pharmacokinetics during continuous arteriovenous haemofiltration.
    de'Clari F
    J Antimicrob Chemother; 1991 Mar; 27(3):394-6. PubMed ID: 2037545
    [No Abstract]   [Full Text] [Related]  

  • 22. Disposition of ceftriaxone in hepatopathic goats following single-intramuscular dosing.
    Sar TK; Mandal TK; Patra PH; Samanta I
    Eur J Drug Metab Pharmacokinet; 2013 Dec; 38(4):269-73. PubMed ID: 23553049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers.
    Chiu LM; Menhinick AM; Johnson PW; Amsden GW
    J Antimicrob Chemother; 2002 Dec; 50(6):1075-9. PubMed ID: 12461037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and bioavailability of cefquinome and ceftriaxone in premature calves.
    Corum O; Yildiz R; Ider M; Altan F; Ok M; Uney K
    J Vet Pharmacol Ther; 2019 Nov; 42(6):632-639. PubMed ID: 31197850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ceftriaxone.
    Blumer J
    Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():7-13; discussion 52-4. PubMed ID: 1918224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
    Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
    Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics and therapeutic efficacy of ceftriaxone in Chinese adults.
    Zhu Z; Wang AX; Li Y
    Chemotherapy; 1997; 43(3):218-26. PubMed ID: 9142464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers.
    Harb G; Lebel F; Battikha J; Thackara JW
    Curr Med Res Opin; 2010 Feb; 26(2):279-88. PubMed ID: 19947907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone pharmacokinetics during cardiopulmonary bypass.
    Oksenhendler G; Leroy A; Schleifer D; Hubscher C; Soyer R
    Chemioterapia; 1987 Jun; 6(2 Suppl):271-2. PubMed ID: 3509410
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
    Gavaldà J; López P; Martín T; Gomis X; Ramírez JL; Azuaje C; Almirante B; Pahissa A
    Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics, urinary and mammary excretion of ceftriaxone in lactating goats.
    Ismail MM
    J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):354-8. PubMed ID: 16109103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
    Barry B; Muffat-Joly M; Bauchet J; Faurisson F; Gehanno P; Pocidalo JJ; Carbon C
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1977-82. PubMed ID: 8878566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
    Pletz MW; Rau M; Bulitta J; De Roux A; Burkhardt O; Kruse G; Kurowski M; Nord CE; Lode H
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3765-72. PubMed ID: 15388432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration.
    Kroh UF; Lennartz H; Edwards DJ; Stoeckel K
    J Clin Pharmacol; 1996 Dec; 36(12):1114-9. PubMed ID: 9013367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic parameters of ceftriaxone after single intravenous and intramuscular administration in camels (Camelus Dromedarius).
    Goudah A
    Res Vet Sci; 2008 Jun; 84(3):483-9. PubMed ID: 17765938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of antibiotics in critically ill patients.
    van Dalen R; Vree TB
    Intensive Care Med; 1990; 16 Suppl 3():S235-8. PubMed ID: 2289997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves.
    Soback S; Ziv G
    Am J Vet Res; 1988 Apr; 49(4):535-8. PubMed ID: 3377315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of ceftriaxone, cefmetazole and moxalactam during abdominal surgery.
    Shinagawa N
    J Chemother; 1989 Jul; 1(4 Suppl):524-5. PubMed ID: 16312514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.